Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis

• Status: Completed
• Trial end date: 2008-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This interventional study aims to evaluate the efficacy of Cyclosporine eye drop treatment in preventing relapses of Vernal Keratoconjunctivitis (VKC) and in treating the acute phases of the disease.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Campus Bio-Medico University
• Collaborators: University of Genova; University of Padova
• Treatments: Cyclosporine; Cyclosporins; Ketotifen; Ophthalmic Solutions; Tetrahydrozoline

Criteria

Inclusion Criteria:

• Patients affected by VKC will be enrolled by the three Centres involved in the project

• Diagnosis of VKC will be performed on the basis of personal and family history of systemic allergic diseases, clinical examination (presence of conjunctival tarsal and/or limbal papillae) and presence of eosinophils in the conjunctival scraping

Exclusion Criteria:

• Contact lens wearers

• Patients affected by other ocular diseases

• Patients subjected to ocular surgery in the preceding 6 months

• Patients under eye drop or systemic treatments for other diseases, or

• Patients enrolled in experimental trials in the preceding 6 months